Population-based validation of a policy change to use long-term androgen deprivation therapy for cT3-4 prostate cancer: Impact of the EORTC22863 and RTOG 85-31 and 92-02 trials

This population-based study demonstrated improved overall survival following a policy change to use of prolonged ADT with curative RT for patients with T3-T4 prostate cancer.